Skip to main content
SpringerLink
Log in

Reproductive endocrinology

Oral enclomiphene citrate in obese men with hypogonadism

  • News & Views
  • Published:

From Nature Reviews Urology

View current issue Sign up to alerts

Testosterone supplementation therapy is an effective therapy for hypogonadism but can lead to the suppression of spermatogenesis. A new study investigated the effects of enclomiphene citrate, the trans isomer of clomiphene, on serum hormone levels and sperm counts in men with secondary hypogonadism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mulligan, T., Frick, M. F., Zuraw, Q. C., Stemhagen, A. & McWhirter, C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int. J. Clin. Pract. 60, 762–769 (2006).

    Article  CAS  Google Scholar 

  2. Pan, M., Ramasamy, R. & Kovac, J. R. Is semen analysis necessary prior to the commencement of testosterone supplementation therapy in men of reproductive age? Can. Urol. Assoc. J. 8, 446–447 (2014).

    Article  Google Scholar 

  3. Huang, E. S. & Miller, W. L. Estrogenic and antiestrogenic effects of enclomiphene and zuclomiphene on gonadotropin secretion by ovine pituitary cells in culture. Endocrinology 112, 442–448 (1983).

    Article  CAS  Google Scholar 

  4. Wiehle, R. et al. Testosterone restoration by enclomiphene citrate in men with secondary hypogonadism: pharmacodynamics and pharmacokinetics. BJU Int. http://dx.doi.org/10.1111/bju.12363 (2013).

  5. Kim, E. D., McCullough, A. & Kaminetsky, J. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement. BJU Int. http://dx.doi.org/10.1111/bju.13337 (2015).

  6. Ramasamy, R., Scovell, J. M., Kovac, J. R. & Lipshultz, L. I. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy. J. Urol. 192, 875–879 (2014).

    Article  CAS  Google Scholar 

  7. Moskovic, D. J., Katz, D. J., Akhavan, A., Park, K. & Mulhall, J. P. Clomiphene citrate is safe and effective for long-term management of hypogonadism. BJU Int. 110, 1524–1528 (2012).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jason R. Kovac is at the Men's Health Center, Urology of Indiana, 8240 Naab Road, Suite 200, Indianapolis, Indiana 46260, USA.,

    Jason R. Kovac

Authors
  1. Jason R. Kovac
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jason R. Kovac.

Ethics declarations

Competing interests

J.R.K. declares that he is a member of the speakers' bureau for AbbVie.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kovac, J. Oral enclomiphene citrate in obese men with hypogonadism. Nat Rev Urol 13, 133–134 (2016). https://doi.org/10.1038/nrurol.2015.311

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2015.311

  • Springer Nature Limited

Search

Navigation